Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 1,035 results for: AAV

Showing: 301 - 320 of 1035 results

  1. pAAV-EF1a-iFlpV (AAV1)

    Viral Prep
    #140137-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-iFlpV (#140137). In addition to the viral particles, you will also receive purified pAAV-EF1a-iFlpV plasmid DNA. EF1a-driven, light-inducible iFlpV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hongkui Zeng
    Article
    Yao et al Nat Methods. 2020 Mar 23. pii: 10.1038/s
    Promoter
    EF1a
    Available Since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only

  2. pAAV-CaMKIIa-EGFP (AAV2)

    Viral Prep
    #50469-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-EGFP (#50469). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-EGFP plasmid DNA. CamKIIa-driven EGFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    CaMKII
    Tags
    EGFP
    Available Since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only

  3. pAAV-ihSyn1-tTA (AAV1)

    Viral Prep
    #99120-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-ihSyn1-tTA (#99120). In addition to the viral particles, you will also receive purified pAAV-ihSyn1-tTA plasmid DNA. Expression of the tet-off transactivator from an inducible synapsin promoter. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.
    Promoter
    ihSyn1
    Available Since
    April 4, 2019
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV-EF1a-C-CreintG (AAV1)

    Viral Prep
    #69571-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-C-CreintG (#69571). In addition to the viral particles, you will also receive purified pAAV-EF1a-C-CreintG plasmid DNA. EF1a-driven expression of optimized C-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-N-CretrcintG (Addgene catalog# 69570) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Connie Cepko
    Article
    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do
    Promoter
    EF1a
    Available Since
    Feb. 19, 2020
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV-EF1a-N-CretrcintG (AAV1)

    Viral Prep
    #69570-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-N-CretrcintG (#69570). In addition to the viral particles, you will also receive purified pAAV-EF1a-N-CretrcintG plasmid DNA. EF1a-driven expression of optimized N-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-C-CreintG (Addgene catalog# 69571) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Connie Cepko
    Article
    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do
    Promoter
    EF1a
    Available Since
    Feb. 19, 2020
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV-CAG-dLight1.2 (AAV1)

    Viral Prep
    #111069-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CAG-dLight1.2 (#111069). In addition to the viral particles, you will also receive purified pAAV-CAG-dLight1.2 plasmid DNA. CAG-driven expression of dLight1.2 dopamine sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Lin Tian
    Article
    Patriarchi et al Science. 2018 Jun 29;360(6396). pii: sci
    Available Since
    Feb. 14, 2022
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV-Ef1a-mCherry (AAV1)

    Viral Prep
    #114470-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Ef1a-mCherry (#114470). In addition to the viral particles, you will also receive purified pAAV-Ef1a-mCherry plasmid DNA. EF1a-driven mCherry expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Promoter
    EF1a
    Tags
    mCherry
    Available Since
    Sept. 15, 2021
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV-hSyn1-eYFP (AAV2)

    Viral Prep
    #117382-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:
    Promoter
    Syn
    Tags
    eYFP
    Available Since
    Feb. 14, 2022
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV.hSynap-FLEX.SF-iGluSnFR.A184V (AAV1)

    Viral Prep
    #106181-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV.hSynap-FLEX.SF-iGluSnFR.A184V (#106181). In addition to the viral particles, you will also receive purified pAAV.hSynap-FLEX.SF-iGluSnFR.A184V plasmid DNA. Synapsin-driven, Cre-dependent expression of glutamate sensor iGluSnFR (medium affinity). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Article
    Marvin et al Nat Methods. 2018 Nov;15(11):936-939. do
    Promoter
    Syn
    Available Since
    March 19, 2021
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-hSyn-GRAB_OTmut (AAV1)

    Viral Prep
    #185388-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn-GRAB_OTmut (#185388). In addition to the viral particles, you will also receive purified pAAV-hSyn-GRAB_OTmut plasmid DNA. hSyn-driven expression of the genetically-encoded fluorescent oxytocin(OT) control sensor GRAB_OTmut in neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Yulong Li
    Article
    Qian et al Nat Biotechnol. 2023 Jan 2. doi: 10.1038
    Promoter
    Syn
    Available Since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV-Ef1a-oScarlet (AAV8)

    Viral Prep
    #137135-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-Ef1a-oScarlet (#137135). In addition to the viral particles, you will also receive purified pAAV-Ef1a-oScarlet plasmid DNA. EF1a-driven expression of oScarlet. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth, INTRSECT 2.0 Project
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    EF1a
    Tags
    oScarlet
    Available Since
    May 6, 2021
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-syn-jYCaMP1s (AAV1)

    Viral Prep
    #135424-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-syn-jYCaMP1s (#135424). In addition to the viral particles, you will also receive purified pAAV-syn-jYCaMP1s plasmid DNA. Synapsin-driven expression of calcium sensor YCaMP1s. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Kaspar Podgorski
    Article
    Mohr et al Nat Methods. 2020 May 25. pii: 10.1038/s
    Promoter
    Syn
    Available Since
    July 22, 2020
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV-CAG-eYFP (AAV2)

    Viral Prep
    #104055-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:
    Promoter
    CAG
    Tags
    EYFP
    Available Since
    June 13, 2023
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV-hSyn1-eYFP (AAV8)

    Viral Prep
    #117382-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:
    Promoter
    Syn
    Tags
    eYFP
    Available Since
    Jan. 6, 2022
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-EF1a-vCre (AAV8)

    Viral Prep
    #55638-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-EF1a-vCre (#55638). In addition to the viral particles, you will also receive purified pAAV-EF1a-vCre plasmid DNA. EF1a-driven expression of VCre. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Article
    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:
    Promoter
    EF1a
    Available Since
    Nov. 12, 2020
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV-hSyn-GRAB_OTmut (AAV9)

    Viral Prep
    #185388-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSyn-GRAB_OTmut (#185388). In addition to the viral particles, you will also receive purified pAAV-hSyn-GRAB_OTmut plasmid DNA. hSyn-driven expression of the genetically-encoded fluorescent oxytocin(OT) control sensor GRAB_OTmut in neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Yulong Li
    Article
    Qian et al Nat Biotechnol. 2023 Jan 2. doi: 10.1038
    Promoter
    Syn
    Available Since
    June 26, 2024
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-CaMKIIa-Flpo (AAV8)

    Viral Prep
    #183535-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-Flpo (#183535). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-Flpo plasmid DNA. CamKIIa-driven expression of Flpo recombinase. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Article
    Fan et al Cell. 2023 Feb 2;186(3):543-559.e19. doi
    Promoter
    CaMKII
    Available Since
    Oct. 8, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV-hSyn1-eYFP (AAV1)

    Viral Prep
    #117382-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hSyn1-eYFP (#117382). In addition to the viral particles, you will also receive purified pAAV-hSyn1-eYFP plasmid DNA. hSyn-driven eYFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:
    Promoter
    Syn
    Tags
    eYFP
    Available Since
    Aug. 15, 2025
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-CAG-emiRFP670 (AAV1)

    Viral Prep
    #197200-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CAG-emiRFP670 (#197200). In addition to the viral particles, you will also receive purified pAAV-CAG-emiRFP670 plasmid DNA. CAG-driven expression of emiRFP670. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Kiryl Piatkevich
    Article
    Zhang et al Nat Methods. 2023 Sep 4. doi: 10.1038/s4
    Available Since
    Feb. 7, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-CAG-tTA (AAV2)

    Viral Prep
    #99118-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CAG-tTA (#99118). In addition to the viral particles, you will also receive purified pAAV-CAG-tTA plasmid DNA. CAG-driven expresssion of tetracycline-controlled transactivator (tTA). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.
    Promoter
    CAG
    Available Since
    June 26, 2024
    Availability
    Academic Institutions and Nonprofits only
Showing: 301 - 320 of 1035 results